A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis®) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma
Authors:
- 1 October 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 66 (2) , 439-444
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Deciphering Erectile Dysfunction Drug TrialsJournal of Urology, 2003
- Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trialUrology, 2003
- Sexual (dys)function after radiotherapy for prostate cancer: a reviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunctionInternational Journal Of Impotence Research, 2001
- Prospective Pilot Study of Sildenafil for Treatment of Postradiotherapy Erectile Dysfunction in Patients With Prostate CancerJournal of Clinical Oncology, 1999
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Comparative Results of Goal Oriented Therapy for Erectile DysfunctionJournal of Urology, 1997
- Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: A preliminary reportInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991